Literature DB >> 14599799

Differential multimerization of Moloney murine leukemia virus integrase purified under nondenaturing conditions.

Rodrigo A Villanueva1, Colleen B Jonsson, Jennifer Jones, Millie M Georgiadis, Monica J Roth.   

Abstract

Retroviral integrases (IN) catalyze the integration of the reverse-transcribed viral DNA into the host genome, an essential process leading to virus replication. For Moloney murine leukemia virus (M-MuLV) IN, the limited solubility of the recombinant protein has restricted the development of biophysical and structural analyses. Herein, recombinant M-MuLV IN proteins, either full length or two nonoverlapping domain constructs, were purified under non-denaturing conditions from solubilized bacterial extracts by Ni(2+)-NTA resins. Additionally, WT IN was further purified by heparin chromatography. All of the purified proteins were shown to be active and stable. WT M-MuLV IN chromatographed with a peak corresponding with a dimer by gel filtration chromatography. In contrast, the single point mutant C209A IN migrated predominantly as a tetramer. For both proteins, fractions in equilibrium between dimers and tetramers were competent to assemble concerted two-end integrations and yielded a unique strand-transfer profile in the presence of a 28-mer U5 oligonucleotide substrate, indicative of a distinct conformation within the synaptic complex. This specific target-site selection was not observed with a shorter 20-mer U5 substrate. These studies provide the foundation for biophysical and structural analysis on M-MuLV IN and the mechanism of retroviral integration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14599799      PMCID: PMC5653259          DOI: 10.1016/s0042-6822(03)00559-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  72 in total

1.  Retroviral integrase functions as a multimer and can turn over catalytically.

Authors:  K S Jones; J Coleman; G W Merkel; T M Laue; A M Skalka
Journal:  J Biol Chem       Date:  1992-08-15       Impact factor: 5.157

2.  Human immunodeficiency virus integrase protein requires a subterminal position of its viral DNA recognition sequence for efficient cleavage.

Authors:  C Vink; D C van Gent; Y Elgersma; R H Plasterk
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

3.  Purification of recombinant Rous sarcoma virus integrase possessing physical and catalytic properties similar to virion-derived integrase.

Authors:  M McCord; S J Stahl; T C Mueser; C C Hyde; A C Vora; D P Grandgenett
Journal:  Protein Expr Purif       Date:  1998-11       Impact factor: 1.650

4.  Zn2+ promotes the self-association of human immunodeficiency virus type-1 integrase in vitro.

Authors:  S P Lee; J Xiao; J R Knutson; M S Lewis; M K Han
Journal:  Biochemistry       Date:  1997-01-07       Impact factor: 3.162

5.  Dissecting the role of the N-terminal domain of human immunodeficiency virus integrase by trans-complementation analysis.

Authors:  F M van den Ent; A Vos; R H Plasterk
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

6.  HIV-1 integrase interaction with U3 and U5 terminal sequences in vitro defined using substrates with random sequences.

Authors:  Elena Brin; Jonathan Leis
Journal:  J Biol Chem       Date:  2002-03-15       Impact factor: 5.157

7.  Formation of a stable complex between the human immunodeficiency virus integrase protein and viral DNA.

Authors:  C Vink; R A Lutzke; R H Plasterk
Journal:  Nucleic Acids Res       Date:  1994-10-11       Impact factor: 16.971

8.  Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations.

Authors:  K A Vincent; V Ellison; S A Chow; P O Brown
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

9.  Retroviral DNA integration: structure of an integration intermediate.

Authors:  T Fujiwara; K Mizuuchi
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

10.  Complementation between HIV integrase proteins mutated in different domains.

Authors:  D C van Gent; C Vink; A A Groeneger; R H Plasterk
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

View more
  6 in total

1.  The GP(Y/F) domain of TF1 integrase multimerizes when present in a fragment, and substitutions in this domain reduce enzymatic activity of the full-length protein.

Authors:  Hirotaka Ebina; Atreyi Ghatak Chatterjee; Robert L Judson; Henry L Levin
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

2.  Post-mitotic BET-induced reshaping of integrase quaternary structure supports wild-type MLV integration.

Authors:  Doortje Borrenberghs; Irena Zurnic; Flore De Wit; Aline Acke; Lieve Dirix; Anna Cereseto; Zeger Debyser; Jelle Hendrix
Journal:  Nucleic Acids Res       Date:  2019-02-20       Impact factor: 16.971

3.  Transcription factor YY1 interacts with retroviral integrases and facilitates integration of moloney murine leukemia virus cDNA into the host chromosomes.

Authors:  Yujin Inayoshi; Yuuki Okino; Katsuhide Miyake; Akifumi Mizutani; Junko Yamamoto-Kishikawa; Yuya Kinoshita; Yusuke Morimoto; Kazuhito Imamura; Mahboob Morshed; Ken Kono; Toshinari Itoh; Ken-ichi Nishijima; Shinji Iijima
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

4.  Removal of nuclease contamination during purification of recombinant prototype foamy virus integrase.

Authors:  Miguel A Lopez; Randi M Mackler; Kristine E Yoder
Journal:  J Virol Methods       Date:  2016-06-05       Impact factor: 2.014

5.  Defining the DNA substrate binding sites on HIV-1 integrase.

Authors:  James Dolan; Aiping Chen; Irene T Weber; Robert W Harrison; Jonathan Leis
Journal:  J Mol Biol       Date:  2008-11-07       Impact factor: 5.469

6.  Crosslinking and mass spectrometry suggest that the isolated NTD domain dimer of Moloney murine leukemia virus integrase adopts a parallel arrangement in solution.

Authors:  Daniel R Henriquez; Caifeng Zhao; Haiyan Zheng; José J Arbildua; Mónica L Acevedo; Monica J Roth; Oscar Leon
Journal:  BMC Struct Biol       Date:  2013-07-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.